Loan N Tran, MD
Radiation Oncology · Saint Helena
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 4
- Since medical school
- 35 years
- Tufts University School of Medicine, 1991
Offices
4 locations · St. Helena Hospital · Northern California Radiation Therapists and Oncologists Medical Group · Northbay Physicians Surgery Center, LLC
Looking this up.
Hospitals listed: Adventist Health St Helena · Alta Bates Summit Medical Center - Alta Bates Camp · Northbay Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tran’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G75743 · Current
Licensed to practise in California · since 1992 · expires 2026-12-31 · Tufts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Radiology - Radiation Oncology
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health St HelenaSaint Helena, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative respiratory failure rate: 15.08 (9.46 to 20.69) · 531 cases, Jul 2022 – Jun 2024
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Northbay Medical CenterFairfield, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Northbay Healthcare, which runs 2 hospitalsPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.6 (11 to 18.8) · 166 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Adventist Health St Helena
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative respiratory failure rateComplications and deaths | 15.08 (9.46 to 20.69) · 531 cases | Worse | Jul 2022 – Jun 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.91 (0 to 1.92) · 430 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.22 (0.89 to 1.55) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 152.62 (102.81 to 202.43) · 69 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 126 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 38 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 953 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.06 to 0.48) · 2,438 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,875 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.24 to 5.59) · 1,095 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.59 (1.12 to 4.05) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.66 (1.18 to 4.13) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.91 (3.32 to 10.5) · 529 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 91 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.51 (0 to 1.32) · 2,008 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 56 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.568 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.362 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 194 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 153 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.2 · 236 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -41 · 178 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -33.9 · 127 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 116 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.8 to 7.9) · 150 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (8.2 to 14.8) · 150 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 59 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.5 to 17.4) · 1,276 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 841 cases | No different | Jan 2024 – Dec 2024 |
What patients said (573 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 34% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Northbay Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.6 (11 to 18.8) · 166 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.08 (0.1 to 2.06) · 1,001 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.7 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 180.67 (132.84 to 228.51) · 88 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.7 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13 · 180 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 338 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 552 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.6 · 238 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 2,034 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.42) · 6,385 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.02 (1.87 to 6.16) · 1,179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.89 (0.26 to 3.51) · 280 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.02 (0.51 to 3.54) · 1,156 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.55 (4.71 to 20.39) · 284 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (1.99 to 9.92) · 276 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.96 (0.48 to 3.43) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1) · 4,549 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 25 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.663 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.985 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.763 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.923 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 420 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.7 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.6 · 439 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25 · 627 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 560 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.7 to 7.9) · 166 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.9 · 210 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.1 (10.5 to 19) · 196 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 250 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,123 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$78,918
Medicare paid this office $78,918 for 107 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Radiation treatment management, 5 treatment sessions | 40 | $15,842 | $165 |
| Ct guidance for insertion of radiation therapy fields | 72 | $15,841 | $38 |
| High precision radiation therapy planning | 33 | $11,880 | $360 |
| Design and construction of radiation treatment device for high precision radiation therapy | 36 | $7,077 | $197 |
| Complex radiation therapy planning | 37 | $5,378 | $142 |
See all 11 services
| Radiation treatment management, 5 treatment sessions | 40 | $15,842 | $165 |
| Ct guidance for insertion of radiation therapy fields | 72 | $15,841 | $38 |
| High precision radiation therapy planning | 33 | $11,880 | $360 |
| Design and construction of radiation treatment device for high precision radiation therapy | 36 | $7,077 | $197 |
| Complex radiation therapy planning | 37 | $5,378 | $142 |
| Design and construction of complex radiation treatment device | 38 | $4,807 | $51 |
| New patient visit (60+ min) | 29 | $4,225 | $146 |
| Calculation of radiation therapy dose | 53 | $3,747 | $27 |
| 3d radiation therapy planning | 18 | $3,498 | $194 |
| Special radiation treatment | 17 | $1,680 | $93 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 13 | $936 | $72 |
Who their Medicare patients are
107 Original Medicare patients in 2024. Average age 73 · Women 54% · Also on Medicaid 24% · Health risk score 1.55. At or below the middle of the specialty; the typical radiation oncology clinician is at 1.69.
Conditions among them: Cancer 75% · High blood pressure 69% · Diabetes 29% · COPD 29% · Chronic kidney disease 23% · Coronary heart disease 22% · Atrial fibrillation 22% · Depression 16% · Stroke 15% · Heart failure 13%.
The office billed $615,747, Medicare allowed $101,182 and paid $78,918; for 978 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 107 | 978 | 73 | 1.55 | $615,747 | $78,918 |
| 2023 | 141 | 632 | 76 | 1.73 | $214,341 | $49,047 |
| 2022 | 89 | 807 | 75 | 1.63 | $235,937 | $55,402 |
| 2021 | 87 | 1,097 | 76 | 1.56 | $316,501 | $76,478 |
| 2020 | 85 | 1,128 | 78 | 1.67 | $316,574 | $75,179 |
| 2019 | 122 | 1,083 | 78 | 2.03 | $297,069 | $69,338 |
| 2018 | 129 | 1,068 | 76 | 1.69 | $376,544 | $81,870 |
| 2017 | 127 | 711 | 75 | 1.51 | $265,673 | $56,900 |
| 2016 | 111 | 711 | 75 | 1.24 | $216,375 | $54,989 |
| 2015 | 95 | 1,503 | 75 | 1.14 | $552,771 | $209,304 |
| 2014 | 249 | 4,611 | 79 | 1.20 | $5,466,052 | $2,851,194 |
| 2013 | 244 | 4,047 | 79 | 1.43 | $4,379,124 | $2,211,530 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Radiation treatment management, 5 treatment sessions | 34 | $11,188 | $167 |
| Ct guidance for insertion of radiation therapy fields | 49 | $7,144 | $39 |
| High precision radiation therapy planning | 11 | $4,770 | $367 |
| Design and construction of complex radiation treatment device | 25 | $3,703 | $53 |
| Complex radiation therapy planning | 22 | $3,196 | $145 |
| Calculation of radiation therapy dose | 22 | $2,574 | $29 |
| New patient visit (60+ min) | 17 | $2,570 | $151 |
| Design and construction of radiation treatment device for high precision radiation therapy | 11 | $2,559 | $197 |
| Return visit (30+ min) | 15 | $1,547 | $81 |
| Short return visit (20+ min) | 26 | $1,384 | $53 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 13 | $935 | $72 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 14 | $673 | $16 |
2022: 12 services
| Radiation treatment management, 5 treatment sessions | 22 | $13,265 | $170 |
| Design and construction of complex radiation treatment device | 26 | $4,720 | $54 |
| Calculation of radiation therapy dose | 25 | $4,383 | $30 |
| Complex radiation therapy planning | 25 | $3,992 | $143 |
| 3d radiation therapy planning | 18 | $3,884 | $204 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 15 | $3,440 | $18 |
| New patient visit (60+ min) | 13 | $2,106 | $162 |
| Short return visit (20+ min) | 27 | $2,063 | $56 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 19 | $1,568 | $75 |
| Short return visit | 37 | $1,520 | $29 |
| Return visit (30+ min) | 16 | $1,384 | $81 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 16 | $616 | $34 |
2021: 14 services
| Radiation treatment management, 5 treatment sessions | 27 | $17,775 | $174 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 20 | $7,182 | $19 |
| Design and construction of complex radiation treatment device | 30 | $6,150 | $55 |
| Complex radiation therapy planning | 30 | $5,516 | $149 |
| Calculation of radiation therapy dose | 30 | $4,984 | $30 |
| 3d radiation therapy planning | 21 | $4,967 | $207 |
| High precision radiation therapy planning | 11 | $4,631 | $386 |
| New patient visit (60+ min) | 18 | $2,994 | $166 |
| Design and construction of radiation treatment device for high precision radiation therapy | 11 | $2,483 | $207 |
| Short return visit (20+ min) | 37 | $2,370 | $56 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 21 | $1,959 | $75 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 18 | $1,606 | $35 |
| Special radiation treatment | 13 | $1,380 | $99 |
| Short return visit | 23 | $876 | $31 |
2020: 13 services
| Radiation treatment management, 5 treatment sessions | 29 | $19,892 | $174 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 27 | $8,556 | $19 |
| High precision radiation therapy planning | 17 | $6,687 | $393 |
| Calculation of radiation therapy dose | 31 | $6,124 | $30 |
| Complex radiation therapy planning | 30 | $4,817 | $155 |
| Design and construction of complex radiation treatment device | 33 | $4,757 | $57 |
| Design and construction of radiation treatment device for high precision radiation therapy | 17 | $4,011 | $211 |
| New patient visit (60+ min) | 25 | $3,803 | $152 |
| 3d radiation therapy planning | 13 | $2,732 | $210 |
| Short return visit (20+ min) | 52 | $2,638 | $41 |
| Special radiation treatment | 16 | $1,702 | $100 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 15 | $1,230 | $77 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 13 | $769 | $33 |
2019: 11 services
| Radiation treatment management, 5 treatment sessions | 27 | $15,887 | $169 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 27 | $7,845 | $19 |
| Design and construction of complex radiation treatment device | 27 | $4,986 | $56 |
| Complex radiation therapy planning | 30 | $4,618 | $149 |
| Calculation of radiation therapy dose | 26 | $4,535 | $30 |
| 3d radiation therapy planning | 18 | $4,171 | $209 |
| Short return visit (20+ min) | 84 | $3,883 | $40 |
| New patient visit (60+ min) | 22 | $3,329 | $151 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 21 | $1,971 | $76 |
| Special radiation treatment | 17 | $1,677 | $99 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 14 | $1,176 | $34 |
2018: 11 services
| Radiation treatment management, 5 treatment sessions | 52 | $20,341 | $168 |
| Design and construction of complex radiation treatment device | 36 | $8,426 | $53 |
| New patient visit (60+ min) | 51 | $7,548 | $148 |
| 3d radiation therapy planning | 25 | $5,956 | $199 |
| Ct guidance for insertion of radiation therapy fields | 26 | $5,133 | $40 |
| Complex radiation therapy planning | 33 | $4,902 | $149 |
| Calculation of radiation therapy dose | 33 | $4,322 | $29 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 29 | $2,355 | $71 |
| Short return visit (20+ min) | 34 | $1,522 | $43 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 24 | $1,489 | $32 |
| Special radiation treatment | 12 | $1,143 | $95 |
2017: 13 services
| Radiation treatment management, 5 treatment sessions | 52 | $11,757 | $168 |
| New patient visit (60+ min) | 52 | $7,780 | $150 |
| Ct guidance for insertion of radiation therapy fields | 34 | $5,984 | $40 |
| Design and construction of complex radiation treatment device | 29 | $5,746 | $53 |
| Complex radiation therapy planning | 30 | $4,759 | $149 |
| 3d radiation therapy planning | 18 | $3,823 | $201 |
| Calculation of radiation therapy dose | 23 | $2,733 | $29 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 28 | $2,280 | $74 |
| Special radiation treatment | 22 | $2,199 | $96 |
| Short return visit (20+ min) | 23 | $1,090 | $44 |
| Ultrasonic guidance for placement of radiation therapy fields | 12 | $819 | $27 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 16 | $725 | $33 |
| Design and construction of simple radiation treatment device | 14 | $300 | $21 |
2016: 11 services
| Radiation treatment management, 5 treatment sessions | 33 | $10,264 | $166 |
| Design and construction of complex radiation treatment device | 27 | $6,282 | $58 |
| Ct guidance for insertion of radiation therapy fields | 17 | $5,438 | $40 |
| New patient visit (60+ min) | 29 | $4,346 | $150 |
| 3d radiation therapy planning | 21 | $4,104 | $195 |
| Complex radiation therapy planning | 23 | $3,279 | $143 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 32 | $2,719 | $73 |
| Short return visit (20+ min) | 30 | $1,551 | $46 |
| Calculation of radiation therapy dose | 14 | $1,428 | $29 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 27 | $1,407 | $33 |
| Special radiation treatment | 14 | $1,370 | $98 |
2015: 15 services
| High dose rate electronic brachytherapy | 18 | $85,295 | $1,854 |
| Radiation treatment management, 5 treatment sessions | 36 | $24,524 | $165 |
| Design and construction of complex radiation treatment device | 37 | $12,801 | $57 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 17 | $10,069 | $272 |
| 3d radiation therapy planning | 38 | $7,479 | $197 |
| Calculation of radiation therapy dose | 47 | $7,266 | $28 |
| New patient visit (60+ min) | 46 | $6,830 | $148 |
| Complex radiation therapy planning | 43 | $6,239 | $145 |
| Ct guidance for insertion of radiation therapy fields | 25 | $5,693 | $39 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 46 | $5,578 | $72 |
| Calculation of radiation therapy dose | 19 | $3,119 | $60 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 37 | $2,979 | $32 |
| Short return visit (20+ min) | 34 | $1,759 | $45 |
| Special radiation treatment | 13 | $1,247 | $96 |
| Special radiation therapy planning for delivery of external radiation | 21 | $912 | $43 |
2014: 14 services
| High dose rate electronic brachytherapy | 179 | $2,323,914 | $1,886 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 180 | $343,420 | $280 |
| Calculation of radiation therapy dose | 181 | $85,004 | $65 |
| Radiation treatment management, 5 treatment sessions | 105 | $23,908 | $165 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 23 | $11,882 | $517 |
| Continuing radiation therapy consultation per week | 104 | $11,206 | $78 |
| Special radiation treatment | 47 | $6,819 | $145 |
| New patient visit (30+ min) | 66 | $6,512 | $99 |
| New patient visit (60+ min) | 38 | $5,574 | $147 |
| Special medical radiation therapy consultation | 44 | $5,257 | $119 |
| Design and construction of simple radiation treatment device | 48 | $5,031 | $80 |
| Design and construction of complex radiation treatment device | 23 | $4,123 | $147 |
| Complex radiation therapy planning | 23 | $3,351 | $146 |
| Simple radiation therapy planning | 27 | $1,931 | $67 |
2013: 19 services
| High dose rate electronic brachytherapy | 141 | $1,854,988 | $1,878 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 141 | $170,335 | $183 |
| Calculation of radiation therapy dose | 145 | $67,834 | $64 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 41 | $23,452 | $545 |
| Radiation treatment management, 5 treatment sessions | 81 | $20,326 | $156 |
| Special radiation treatment | 48 | $7,243 | $142 |
| Design and construction of complex radiation treatment device | 29 | $6,347 | $148 |
| Complex radiation therapy planning | 43 | $6,123 | $139 |
| Continuing radiation therapy consultation per week | 81 | $5,944 | $45 |
| New patient visit (60+ min) | 40 | $5,834 | $146 |
| Special medical radiation therapy consultation | 44 | $5,788 | $123 |
| New patient visit (30+ min) | 50 | $4,908 | $98 |
| Design and construction of simple radiation treatment device | 41 | $4,471 | $80 |
| Design and construction of complex radiation treatment device | 16 | $2,527 | $55 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 28 | $2,288 | $69 |
| Complex radiation therapy planning | 16 | $2,258 | $141 |
| Ct guidance for insertion of radiation therapy fields | 27 | $1,954 | $38 |
| Calculation of radiation therapy dose | 14 | $1,824 | $28 |
| X-ray guidance for radiation therapy delivery | 12 | $1,021 | $17 |
Medicaid work
$1,044 in 2023
Medicaid paid $1,044 for 27 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Computed tomography guidance for placement of radiation therapy fields | 27 | $1,044 |
| 2023 | 27 | 1 | 13 | $1,044 |
Drugs they prescribed that Part D paid
$752
Pharmacies billed $752 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
28 generic and 0 brand-name prescriptions · $752 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 28 | 18 | None | 0% | $752 |
| 2023 | 24 | 19 | None | None | $463 |
| 2022 | 20 | 11 | None | 0% | $378 |
| 2021 | 36 | 13 | 56% (20) | None | $2,040 |
| 2020 | 33 | 12 | 70% (23) | None | $1,907 |
| 2019 | 38 | 19 | 45% (17) | None | $3,963 |
| 2018 | 31 | 14 | None | 52% | $5,899 |
| 2017 | 49 | 23 | 29% (14) | 53% | $8,316 |
| 2016 | 71 | 20 | 17% (12) | 56% | $12,371 |
| 2015 | 66 | 23 | 21% (14) | 56% | $11,438 |
| 2014 | 86 | 23 | None | 74% | $11,069 |
| 2013 | 138 | 36 | None | 72% | $15,958 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 1 drug
| Hydrocodone-Acetaminophen | 13 | $426 | $33 |
2016: 1 drug
| Travatan Z | 18 | $3,349 | $186 |
2015: 1 drug
| Travatan Z | 13 | $2,780 | $214 |
2014: 3 drugs
| Travatan Z | 17 | $1,994 | $117 |
| Istalol | 17 | $1,975 | $116 |
| Timolol Maleate | 11 | $292 | $27 |
2013: 6 drugs
| Restasis | 19 | $6,339 | $334 |
| Lumigan | 15 | $2,864 | $191 |
| Travatan Z | 15 | $1,523 | $102 |
| Istalol | 12 | $976 | $81 |
| Timolol Maleate | 12 | $250 | $21 |
| Latanoprost | 12 | $187 | $16 |
Money from drug and device companies
$594 in 2025
| 2025 | 10 | 16 | None | $594 |
| 2024 | 5 | 7 | None | $194 |
| 2023 | 2 | 2 | None | $48 |
| 2022 | 3 | 4 | None | $87 |
| 2021 | 1 | 1 | None | $19 |
| 2020 | 2 | 3 | None | $48 |
| 2019 | 5 | 11 | None | $332 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Incyte | Jakafi | $125 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Abecma | $115 | 1 payment
|
| Myriad Genetic Laboratories | Precisetumor | $80 | 4 payments
|
| Napo Pharmaceuticals | Gelclair Concentrated Oral Gel | $65 | 3 payments
|
| Novartis Pharmaceuticals | Pluvicto | $53 | 2 payments
|
| Teleflex | Barrigel | $43 | 1 payment
|
See all 16 published payments
| Napo Pharmaceuticals | Meals · 2025-10-31 | Gelclair Concentrated Oral Gel | $20 |
| Teleflex | Meals · 2025-10-24 | Barrigel | $43 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-19 | Nubeqa | $27 |
| Napo Pharmaceuticals | Meals · 2025-08-15 | Gelclair Concentrated Oral Gel | $16 |
| Novartis Pharmaceuticals | Meals · 2025-07-21 | Pluvicto | $31 |
| Napo Pharmaceuticals | Meals · 2025-07-18 | Gelclair Concentrated Oral Gel | $28 |
| Novartis Pharmaceuticals | Meals · 2025-05-27 | Kisqali | $22 |
| Incyte | Meals · 2025-05-06 | Jakafi | $125 |
| Merck Sharp & Dohme | Meals · 2025-04-29 | Keytruda | $28 |
| Myriad Genetic Laboratories | Meals · 2025-04-22 | Precisetumor | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-26 | Abecma | $115 |
| Myriad Genetic Laboratories | Meals · 2025-03-18 | Precisetumor | $24 |
| Novocure | Meals · 2025-03-04 | Optune Lua (Novottf-200t) | $23 |
| Janssen Biotech | Meals · 2025-02-25 | Rybrevant | $35 |
| Myriad Genetic Laboratories | Meals · 2025-02-18 | Precisetumor | $19 |
| Myriad Genetic Laboratories | Meals · 2025-01-14 | Precisetumor | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $194
| Merck Sharp & Dohme | Keytruda | $82 | 3 payments
|
| Janssen Biotech | Rybrevant | $35 | 1 payment
|
| Lilly USA | Jaypirca | $30 | 1 payment
|
| Daiichi Sankyo | Enhertu | $28 | 1 payment
|
| Eisai | Lenvima | $20 | 1 payment
|
2023: $48
| Novartis Pharmaceuticals | Pluvicto | $34 | 1 payment
|
| Janssen Biotech | Erleada | $14 | 1 payment
|
2022: $87
| Amgen | Nplate | $48 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $21 | 1 payment
|
| ViiV Healthcare | Apretude | $18 | 1 payment
|
2021: $19
| Sanofi-Aventis U.S. | Libtayo | $19 | 1 payment
|
2020: $48
| Merck Sharp & Dohme | Keytruda | $35 | 2 payments
|
| Lilly USA | Emgality | $13 | 1 payment
|
2019: $332
| AstraZeneca Pharmaceuticals LP | Tagrisso | $122 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $86 | 5 payments
|
| Bayer HealthCare Pharmaceuticals | Xofigo | $68 | 3 payments
|
| Elekta | Mosaiq | $36 | 1 payment
|
| Varian Medical Systems | None | $19 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1043292410
- Licence
- CA G75743California G75743: Current · expires 2026-12-31
- Trained
- Tufts University School of Medicine, 1991 · 35 years ago
- Group
- St. Helena Hospital · Northern California Radiation Therapists and Oncologists Medical Group · Northbay Physicians Surgery Center, LLC
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G757430
- Taxonomy
- Federal specialty code 2085R0001X (2085R0001X)
- Mailing address
- 1450 Treat Blvd Ste 300, Walnut Creek, CA, 94597
- NPI first listed
- 2005-11-18
- NPI last updated
- 2022-11-14
- NPI record certified
- 2022-11-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 701 E. El Camino Real, Mountain View, CA, 94040